Merck, Mettler Toledo and Thermo Fisher Scientific are key players in the Global Bioburden Testing Market

The report published by Knowledge Sourcing Intelligence titled “Global Bioburden Testing Market - Forecast From 2018 to 2023” studies the various factors affecting the market for bioburden testing worldwide. The report has been segmented by products used (consumables, instruments), application (raw material testing, medical devices testing, in-process testing, others) and end users (pharmaceuticals and biopharmaceutical manufacturers, CMOs, medical device manufacturers).

In addition, the market for bioburden testing has been estimated based on the geography, covering five regions namely North America, South America, Europe, Middle East and Africa, and Asia Pacific, and some of the major economies in each of these regions. Growth may be attributed to the rise in the pharmaceutical and medical device industry coupled with stringent regulatory compliance. High frequency of product recall due to microbial contamination will also boost the market for bioburden testing through to 2023. However, the high cost of the bioburden testing instruments coupled with a time-consuming approval process might restrain the growth of the market during the given time frame.

Request Sample: www.knowledge-sourcing.com/requestsample&sample_id=2024

By End User, CMO segment is expected to grow at a robust CAGR during the given forecast period

It is estimated that the CMO segment will show robust growth during the given forecast period. The growth may be attributed to the grow owing to the increasing outsourcing of manufacturing processes from pharmaceutical and biotechnology companies to CMOs coupled with the rising number of CMOs across the globe.

The North America region is estimated to dominate the market throughout the forecast period.

The demand for nuclear medicine was comparatively high in the North America region owing to the rising R&D investments in life sciences research coupled with the rising government support to the biotech and pharmaceutical companies in the region whereas Asia–Pacific is expected to grow at a robust CAGR during the given time frame. The growth is fuelled by the rising number of research activities coupled with the increasing trend of pharmaceutical outsourcing to Asian countries.

This report also includes a study of strategies and product portfolios of some of the leading companies in the global bioburden testing market. It consists of company profiles of the leading companies such as Merck, Mettler Toledo, and Thermo Fisher Scientific, among others.

Request customization or place an order: www.knowledge-sourcing.com/global-bioburden-testing-market

About Us:
Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

Contact:
Knowledge Sourcing Intelligence LLP
2nd Floor, D-77, Sector 63
Noida, U.P. - 201301
India
E: sales@knowledge-sourcing.com | P: +1-866-714-4587

This release was published on openPR.